Literature DB >> 24951315

Quantitative analysis of the suppressors of cytokine signaling 1 and 3 in peripheral blood leukocytes of patients with multiple sclerosis.

Virginia Sedeño-Monge1, Raúl Arcega-Revilla2, Emmanuel Rojas-Morales3, Gerardo Santos-López4, Juan Carlos Perez-García5, Francisca Sosa-Jurado4, Verónica Vallejo-Ruiz4, Casandra Lucrecia Solis-Morales6, Salvador Aguilar-Rosas7, Julio Reyes-Leyva4.   

Abstract

Multiple sclerosis (MS) is an autoimmune disease characterized by a triad of inflammation, demyelination and gliosis. Because the suppressors of cytokine signaling (Socs) regulate the immune response, we quantified SOCS1 and SOCS3 transcription in peripheral blood leukocytes of patients with MS. SOCS1 transcription decreased significantly in MS patients compared with neurologically healthy persons (0.08±0.02 vs. 1.02±0.23; p=0.0001); while SOCS3 transcription increased in MS patients compared with controls (2.76±0.66 vs. 1.03±0.27; p=0.0008). Our results showed an imbalance of SOCS1 and SOCS3 transcription in MS patients, and a moderated negative correlation between them (Spearman's r=-0.57; p=0.0003).
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  IFN-β; Multiple sclerosis; SOCS1; SOCS3

Mesh:

Substances:

Year:  2014        PMID: 24951315     DOI: 10.1016/j.jneuroim.2014.05.013

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

1.  Expression of suppressor of cytokine signaling genes in human elderly and Alzheimer's disease brains and human microglia.

Authors:  D G Walker; A M Whetzel; L-F Lue
Journal:  Neuroscience       Date:  2014-10-05       Impact factor: 3.590

2.  Radio Electric Asymmetric Conveyer Technology Modulates Neuroinflammation in a Mouse Model of Neurodegeneration.

Authors:  Maria Antonietta Panaro; Alessandra Aloisi; Giuseppe Nicolardi; Dario Domenico Lofrumento; Francesco De Nuccio; Velia La Pesa; Antonia Cianciulli; Rosaria Rinaldi; Rosa Calvello; Vania Fontani; Salvatore Rinaldi
Journal:  Neurosci Bull       Date:  2017-11-10       Impact factor: 5.203

Review 3.  Toll-Like Receptor Pathways in Autoimmune Diseases.

Authors:  Ji-Qing Chen; Peter Szodoray; Margit Zeher
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

Review 4.  Seeking balance: Potentiation and inhibition of multiple sclerosis autoimmune responses by IL-6 and IL-10.

Authors:  Sara J Ireland; Nancy L Monson; Laurie S Davis
Journal:  Cytokine       Date:  2015-03-17       Impact factor: 3.861

5.  Quantitative detection of methylated SOCS-1 in schizophrenia and bipolar disorder considering SOCS-1 -1478CA/del polymorphism and clinical parameters.

Authors:  Hasan Mervan Aytac; Sacide Pehlivan; Mustafa Pehlivan; Yasemin Oyaci
Journal:  Ir J Med Sci       Date:  2022-05-20       Impact factor: 1.568

6.  Open label safety and efficacy pilot to study mitigation of equine recurrent uveitis through topical suppressor of cytokine signaling-1 mimetic peptide.

Authors:  Caryn E Plummer; Timothy Polk; Jatin Sharma; Sanghyo Sarah Bae; Olivia Barr; Amari Jones; Holly Kitchen; Michelle Wilhelmy; K Devin; W Clay Smith; Bryan D Kolaczkowski; Joseph Larkin
Journal:  Sci Rep       Date:  2022-05-03       Impact factor: 4.996

7.  Suppressor of Cytokine Signaling (SOCS)1 Regulates Interleukin-4 (IL-4)-activated Insulin Receptor Substrate (IRS)-2 Tyrosine Phosphorylation in Monocytes and Macrophages via the Proteasome.

Authors:  Sarah M McCormick; Nagaraj Gowda; Jessie X Fang; Nicola M Heller
Journal:  J Biol Chem       Date:  2016-08-09       Impact factor: 5.157

Review 8.  Regulation of Macrophage, Dendritic Cell, and Microglial Phenotype and Function by the SOCS Proteins.

Authors:  Sarah M McCormick; Nicola M Heller
Journal:  Front Immunol       Date:  2015-10-27       Impact factor: 7.561

9.  Differential Transcription of SOCS5 and SOCS7 in Multiple Sclerosis Patients Treated with Interferon Beta or Glatiramer Acetate.

Authors:  Emmanuel Rojas-Morales; Gerardo Santos-López; Samuel Hernández-Cabañas; Raúl Arcega-Revilla; Nora Rosas-Murrieta; Carolina Jasso-Miranda; Elie Girgis El-Kassis; Julio Reyes-Leyva; Virginia Sedeño-Monge
Journal:  Int J Mol Sci       Date:  2019-12-28       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.